Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Dr RR Baliga's "Got Knowledge Doc" Podkast · MasterMedFacts.com
September 23, 20218m 26s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343
Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion